Skip to main content
Log in

Combined Poly(isobutylcyanoacrylate) and Cyclodextrins Nanoparticles for Enhancing the Encapsulation of Lipophilic Drugs

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The aim of this study was to prepare and characterize nanoparticulate systems constituted of poly(isobutylcyanoacrylate) and cyclodextrins and intended for increasing the loading of the particles with lipophilic substances. Progesterone was used as a model substance.

Methods. Nanoparticles were prepared by polymerization of isobutyl-cyanoacrylate in presence of cyclodextrins or progesterone/ hydroxy-propyl-β-cyclodextrin complex. Particle size, zeta potential, cyclodextrin and progesterone loading of the particles were determined.

Results. Nanoparticles could be easily prepared in presence of cyclodextrins. An increase in hydroxypropyl-β-cyclodextrin concentration resulted in small nanoparticles (less than 50 nm). It was found that large amounts of cyclodextrins remained associated to the particles, resulting in a 50 fold increase in progesterone loading compared to nanoparticles prepared in absence of cyclodextrins.

Conclusions. The poly(isobutylcyanoacrylate)—cyclodextrin nanoparticles were characterized by the presence of many lipophilic sites belonging to the cyclodextrins which were firmly anchored to the structure of the particles. Therefore, this new type of nanoparticles offers probably an opportunity for increasing the loading of nanoparticles with various lipophilic drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. J. Kreuter. Nanoparticles. In J. Kreuter (ed.), Colloidal Drug Delivery Systems, Marcel Decker, New York, 1994, pp. 219–342.

    Google Scholar 

  2. P. Couvreur, M. Roland, and P. Speiser. Biodegradable submicronic particles containing a biologically active substance and compositions containing then. U.S. Patent N o 4, 329–332, 1982.

    Google Scholar 

  3. M. Vikmon. Rapid and simple spectrophotometric method for determination of micro-amounts of cyclodextrins. Proceed. First International Symposium in Cyclodextrins, Budapest, 69–74, 1981.

  4. S. J. Douglas, L. Illum, and S. Davis. Particle size distribution of poly(butyl 2-cyanoacrylate) nanoparticles. J. Colloid. Interf. Sci. 103:154–163 (1985).

    Google Scholar 

  5. C. Lourenço, M. Teixeira, S. Simões, and R. Gaspar. Steric stabilization of nanoparticles: size and surface properties. Int. J. Pharm. 138:1–12 (1996).

    Google Scholar 

  6. F. W. Lichtenthaller and S. Immel. The lipophilicity patterns of cyclodextrins and of non-glucose cyclooligosaccharides. Proceed. Eigth International Symposium of Cyclodextrins, 3–16, 1996.

  7. M. Gallardo, G. Couarraze, B. Denizot, L. Treupel, P. Couvreur, and F. Puisieux. Study of the mecanisms of formation of nanoparticles and nanocapsules of polyisobutyl-2-cyanoacrylate. Int. J. Pharm. 100:55–64 (1993).

    Google Scholar 

  8. C. Verdun, P. Couvreur, H. Vranckx, V. Lenaerts, and M. Roland. Development of a nanoparticle controlled-release formulation for human use. J. Control. Rel. 3:205–210 (1986).

    Google Scholar 

  9. M. Fresta and G. Puglisi. Association of netilmicin sulphate to poly(alkylcyanoacrylate) nanoparticles: Factors influencing particle delivery behaviour. Drug Dev. Ind. Pharm. 20:2227–2243 (1994).

    Google Scholar 

  10. B. Seijo, E. Fattal L. Roblot-Treupel, and P. Couvreur. Design of nanoparticles of less than 50 nm diameter: preparation, characterization and drug loading. Int. J. Pharm. 62:1–7 (1990).

    Google Scholar 

  11. Ch. Tasset, N. Barette, S. Thysman, J. M. Ketelsgers, D. Lemoine, and V. Préat. Polyisobutylcyanoacrylate nanoparticles as sustained release system for calcitonin. J. Control. Rel. 33:23–30 (1995).

    Google Scholar 

  12. V. H. K. Li, R. Wood, J. Kreuter, T. Harmia, and J. Robinson. Ocular drug delivery of progesterone using nanoparticles. J. Microencapsul. 3:213–218 (1986).

    Google Scholar 

  13. S.-Z. Lin, M. Skiba D. Wouessidjewe, B. Agnus, and D. Duchêne. Inclusion complexes of progesterone and its analogue x with cyclodextrins. Proceed. 6th International Symposium on Cyclodextrins, Chicago, U.S.A., 460–465, 1992.

  14. M.-C. Venier-Julienne and J. P. Benoit. Preparation, purification and morphology of polymeric nanoparticles as drug carriers. Pharmaceutica Acta Helvetiae, 7:121–128 (1996).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

da Silveira, A.M., Ponchel, G., Puisieux, F. et al. Combined Poly(isobutylcyanoacrylate) and Cyclodextrins Nanoparticles for Enhancing the Encapsulation of Lipophilic Drugs. Pharm Res 15, 1051–1055 (1998). https://doi.org/10.1023/A:1011982211632

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011982211632

Navigation